Syria’s Minister of Health, Rida Said, announced last week that the number of people having died from swine flu in Syria had reached 50.
The Syrian Cabinet has confirmed the decision of the Syrian Jordanian Committee last October to lift restrictions on the trade of pharmaceuticals between the two countries.
A Presidential decree has banned smoking in all public spaces in Syria.
Syria's Ministry of Health has said that the total number of swine flu cases in the country has reached 37, out of which two patients died.
Siemens Healthcare Consulting has been appointed to design and supervise the construction of a private hospital in the city of Homs.
Syria's Ministry of Health has confirmed that the first case of swine flu was found in the country.
GlaxoSmithKline announced on July 02 that it was developing its business in the Middle East region through the purchase of the branded generics business of Bristol Myers Squibb (BMS) in Lebanon, Jordan, Syria, Libya and Yemen.
Two new Syrian drug manufacturers have been certified by EU-accredited inspectors to export their products to the European market.
Syrian exports of pharmaceuticals stood at USD 150 million in 2007, according to Zouheir Fadaloun, secretary general of the Scientific Council for Pharmaceutical Industries.
Julphar, one of largest pharmaceutical manufacturers in the UAE, is looking at the opportunity of investing in Syria.
Four Syrian drug manufacturers have received a statement of international Good Manufacturing Practices.
The Syrian Investment Authority has licensed the set-up of two medical compounds at a combined investment value of SYP 8.4 billion.
The ruler of the United Arab Emirates, Sheikh Khalifa bin Zayed Al Nahyan, has granted the Syrian government USD 100 million to build a state-owned hospital.
According to the latest projections of the Ministry of Health, the number of new cases of infections from acquired immune deficiency syndrome (Aids) will grow dramatically in Syria the coming three years
National Company for Pharmaceutical Industry, an Aleppo-based pharmaceutical manufacturing company, has been found to meet European and WHO Good Manufacturing Practice norms.
Damascus International Fairground
First Forum on Eco-friendly products